The rationale behind a vaccine based on multiple HIV antigens
- PMID: 16257558
- DOI: 10.1016/j.micinf.2005.07.017
The rationale behind a vaccine based on multiple HIV antigens
Abstract
The viral diversity of HIV-1 is likely to require a vaccine strategy that induces broad cellular and humoral anti-HIV-1 immunity. Our strategy is based on multiple HIV-1 DNA immunogens together with adjuvant recombinant granulocyte-macrophage stimulating factor. This article describes pre-clinical and clinical work preceding the initiation of clinical HIV-1 phase I/II trials.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
